Efficacy and safety of ozonated autohemotherapy in patients with hyperuricemia and gout: A phase I pilot study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Ozone alleviates MSU-induced acute gout pain via upregulating AMPK/GAS6/MerTK/SOCS3 signaling pathway.Journal of translational medicine · 2023
   Article
2. Expert consensus of Chinese Association for the Study of Pain on the application of ozone therapy in pain medicine.World journal of clinical cases · 2021
   Review
3. Detection of chlorite, chlorate and perchlorate in ozonated saline.Experimental and therapeutic medicine · 2020
   Article
4. Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients.Open access rheumatology : research and reviews · 2017
   Article
5. Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury.Inflammation · 2016
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as